Old Web
English
Sign In
Acemap
>
Paper
>
Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation
Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation
2016
Ll Poyatos Ruiz
Vega-Coca
S. Flores Moreno
A Garcia-Avello
L Abdel-Kader Martín
C. Calderón Cabrera
Keywords:
Refractory
Oncology
Intensive care medicine
Off-label use
Stem cell
Graft-versus-host disease
Transplantation
Ruxolitinib
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]